RASSF8 and RASSF10 suppress cell proliferation, migration and invasion in gastric cancer, lung cancer, liver cancer, cervical cancer, colorectal cancer and esophageal squamous cell carcinoma [30–34]. Here, RASSF8 is linked to cervical cancer.